Introduction
============

Sleepiness impairs social function, reduces quality of life and causes occupational and motor vehicle accidents^\[[@R1]\]^. While behavioral factors, circadian factors (time of day), duration of wakefulness and sleep disorders are closely linked to daytime sleepiness^\[[@R2]\]^, there are great interindividual differences in susceptibility to sleepiness^\[[@R3]\]^. Accumulating evidence shows that excessive sleepiness is heritable^\[[@R4]--[@R5]\]^. In modern society, nearly one-fifth of employees are involved in long-term night shift^\[[@R6]\]^. As a result, work performance and scheduling have a significant impact on individual variability in diurnal preference. Studies also indicate that diurnal preference (namely usual weekday bedtime) is heritable^\[[@R7]--[@R9]\]^. In addition, usual weekday sleep duration plays a critical role in daytime sleepiness. It has been investigated whether short or long sleep duration has been related to coronary heart disease^\[[@R10]\]^, diabetes mellitus^\[[@R11]--[@R12]\]^, hypertension^\[[@R13]\]^, and mortality^\[[@R14]\]^. Likewise, usual day sleep duration is heritable^\[[@R15]\]^.

To date, several single nucleotide polymorphisms (SNPs) associated with circadian phenotypes in some genes were detected from three genome-wide association studies (GWASs)^\[[@R16]--[@R18]\]^, but the functions of these SNPs remain undefined, which is a challenge in interpreting GWAS results^\[[@R19]\]^. Thus, pathway-based approaches were optimized gradually, and the Identify Candidate Causal SNPs and Pathways (ICSNPathway) was created to determine potential SNPs and hypothetical mechanisms through GWAS data, using linkage disequilibrium (LD) analysis, functional SNP annotation and pathway-based analysis (PBA)^\[[@R20]\]^. Herein, we used bioinformatics methods combining ICSNPathway analysis and HapMap database to identify candidate SNPs and relevant pathways, aiming to develop SNP-gene-pathway hypotheses regarding circadian phenotypes.

Materials and methods
=====================

Study population and data extraction
------------------------------------

We applied publicly available databases to identify eligible GWASs on circadian phenotypes, which are the National Human Genome Research Institute GWAS catalog (http://www.genome.gov/26525384), the National Center for Biotechnology Information (NCBI) dbGap (http://www.ncbi.nlm.nih.gov/gap/), and the GWAS central (http://www.gwascentral.org/). In addition, both EMBASE and PUBMED databases were searched with the following key words: "GWAS" or "genome-wide association study" and "circadian". All searches were completed up to April 20th, 2016 without language limitation. In order to reduce the effect of genotyping errors, two independent authors (DZ and JYuan) filtered the primary GWAS data set and removed individuals with a call rate\<95%, minor allele frequency\<0.01, and deviating from the Hardy-Weinberg equilibrium (HWE) test (*P*\<0.001). During data extraction, discussion with a third author (YW) helped resolve the discrepancies, with consensus on each item reached in the end. After extracting data from the original papers and contacting the corresponding authors, we ruled out the studies without details as needed.

Identification of candidate causal SNPs and pathways
----------------------------------------------------

ICSNPathway analysis was conducted in two consecutive stages. In the first stage, the candidate SNPs were pre-selected by LD analysis and functional SNP annotation with *P* values of \<0.05^\[[@R20]\]^. During the LD analysis, we queried GWAS to capture the SNPs in LD (with *r*^2^\>0.8) and positioned in the flanking region (with up to 500 kb upstream and downstream) . The extended dataset including HapMap data (http://hapmap.ncbi.nlm.nih.gov) was utilized to obtain more possible candidate SNPs^\[[@R21]\]^. Additionally, to gain LD structures, we used SNAP dataset (http://www.broadinstitute.org/mpg/snap/)^\[[@R22]\]^. The other method involves the functional annotation on the SNPs by searching the international SNP function annotation databases, including PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/)^\[[@R23]\]^, Ensembl database (http://www.ensembl.org)^\[[@R24]\]^, SNPs3D (http://www.snps3d.org)^\[[@R25]\]^, and SIFT (http://sift.jcvi.org)^\[[@R26]\]^.

Genotypic frequencies of candidate SNPs was extracted from the International HapMap Project (phase II, release 23), consisting of 3.96 million SNP genotypes from 270 subjects^\[[@R27]\]^. Besides, the data of corresponding mRNA expression was acquired from lymphoblastic cell lines of the 270 individuals mentioned above^\[[@R28]\]^, which was extracted from SNPexp (http://app3.titan.uio.no/biotools/help.php?app=snpexp/)^\[[@R29]\]^.

During the second stage, PBA algorithm was employed to annotate biological pathways of selected SNPs by integrating data from four databases, including BioCarta (http://www.biocarta.com), MsiDB (http://www.broadinstitute.org/gsea/msigdb), Kyoto Encyclopedia of Genes and Genomes (KEGG, http://www.genome.jp/kegg) and gene ontology (GO, http://www.geneontology.org). Furthermore, SNP label normalization and permutation were adopted to correct gene variations and generate the distribution of significant proportion based enrichment score (SPES).According to the distributions of SPESs, a nominal *P*-value and a FDR (false discovery rate; cutoff value: 0.05) were calculated.

Statistical analysis
--------------------

The expression levels were shown as mean±SEM, and the difference between two genotypes was evaluated by two-side Student\'s *t* test. Furthermore, one way ANOVA was utilized to assess the difference of transcript expression levels in more than two genotypes. The statistical analysis was performed with SPSS version 21.0. *P* values\<0.05 were considered statistically significant.

Results
=======

Characteristics of the study population
---------------------------------------

One GWAS drawn from NCBI dbGap (study accession: phs000007) was finally adopted in our study^\[[@R16]\]^ with publicly available summary data after a thorough search. In the GWAS on circadian phenotypes(including usual weekday bedtime and usual weekday sleep duration), totally 749 subjects were collected from the Framingham Offspring Study containing 2848 participants who accomplished sleep habit questionnaires between 1995 and 1998 (Offspring Examination Cycle 6) for the Sleep Heart Health Study^\[[@R30]\]^. For usual weekday bedtime, 65,514 candidate causative SNPs were originally generated with an Affymetrix 100K SNP Gene Chip, and afterwards 47,285 SNPs passed the quality control filters which were employed for ultimate bioinformatics analysis. Besides, for usual weekday sleep duration, 65,514 SNPs were generated with the gene chip, while 47,301 SNPs met the quality control criterions and were then applied for subsequent analysis.

Candidate SNPs and pathways
---------------------------

As presented in ***Table 1***, totally four SNPs in three genes were determined to correlate with usual weekday bedtime, namely, MT-ND5 rs10517616, GRSF1 rs3775728, and ENAM rs7671281, rs3796704 polymorphisms. Moreover, eleven SNPs in six genes were identified to correlate with usual weekday sleep duration, namely, HSPD1 rs8539, APOBEC2 rs2076472, GRSF1 rs3775728, TTN rs9808377, rs1001238, rs2042995, rs3829746, rs2042996, CENPE rs2243682, rs2615542 and SLC17A1 rs13213957. Of note, GRSF1 rs3775728 was linked with both usual weekday bedtime and usual weekday sleep duration. SNP rs3775728 was in LD with rs2278134 (*r*^2^=1.0) ; rs7671281 and rs3796704 were in LD with rs2553319 (*r*^2^=1.0, and 1.0, respectively); rs9808377, rs1001238 and rs2042995 were in LD with rs3829746 (*r*^2^=0.945, 0.946, and 0.945, respectively); rs2243682 and rs2615542 were in LD with rs2290943 (*r*^2^=1.0, and 1.0, respectively); SNP rs13213957 was in LD with rs3734523 (*r*^2^=0.828). Except for a repeated SNP, fourteen regional LD plots are shown in ***Fig. 1***.

###### 

Candidate single nucleotide polymorphisms identified by ICSNPathway analysis

  SNP ID                         Functional class                    Gene        Chromosome   Candidate- pathway^a^   -log~10~(P)^b^   In LD with   *r*^2^   D\'   -log~10~(P)^c^
  ------------------------------ ----------------------------------- ----------- ------------ ----------------------- ---------------- ------------ -------- ----- ----------------
  Usual weekday bedtime                                                                                                                                            
  rs10517616                     nonsynonymous coding                *MT-ND5*    4            1,2,4,6                 1.49             rs10517616   NA       NA    1.49
  rs3775728                      nonsynonymous coding                *GRSF1*     4q13         3                       NA               rs2278134    1        1     1.664
  rs7671281                      nonsynonymous coding                *ENAM*      4q13.3       5                       NA               rs2553319    1        1     1.342
  rs3796704                      nonsynonymous coding(deleterious)   *ENAM*      4q13.3       5                       NA               rs2553319    1        1     1.342
  Usual weekday sleep duration                                                                                                                                     
  rs8539                         nonsynonymous coding                *HSPD1*     2q33.1       1                       1.62             rs8539       NA       NA    1.62
  rs2076472                      nonsynonymous coding                *APOBEC2*   6p21         2                       1.533            rs2076472    NA       NA    1.533
  rs3775728                      nonsynonymous coding                *GRSF1*     4q13         2,4,6                   NA               rs2278134    1        1     1.881
  rs9808377                      nonsynonymous coding                *TTN*       2q31         3                       NA               rs3829746    0.945    1     1.567
  rs1001238                      nonsynonymous coding                *TTN*       2q31         3                       NA               rs3829746    0.946    1     1.567
  rs2042995                      nonsynonymous coding                *TTN*       2q31         3                       NA               rs3829746    0.945    1     1.567
  rs3829746                      nonsynonymous coding                *TTN*       2q31         3                       1.567            rs3829746    NA       NA    1.567
  rs2042996                      nonsynonymous coding                *TTN*       2q31         3                       1.423            rs2042996    NA       NA    1.423
  rs2243682                      nonsynonymous coding(deleterious)   *CENPE*     4q24-q25     3                       NA               rs2290943    1        1     1.418
  rs2615542                      nonsynonymous coding                *CENPE*     4q24-q25     3                       NA               rs2290943    1        1     1.418
  rs13213957                     regulatory region                   *SLC17A1*   6p22.2       5                       NA               rs3734523    0.828    1     1.605

SNP: single nucleotide polymorphism; LD: linkage disequilibrium; NA: not available. ^a^The number indicates the index of pathways ranked by their statistical significance (false discovery rate). ^b^−log~10~(P) for candidate SNP in the original genome wide association study (GWAS). ^c^−log~10~(P) for the SNP in the original GWAS which was in LD with candidate SNP.

Fig.1Detailed LD plots for the polymorphisms.

Then, we examined the roles of different genotypes in mRNA expression levels via HapMap c-DNA expression database which was publicly available. No significant association between all SNPs with the mRNA expressions of corresponding genes was found in Caucasians as presented in ***Table 2***. However, the SLC17A1 rs13213957 polymorphisms might tend to affect the mRNA expression levels of SLC17A1 (with marginal *P* value=0.0785), which is consistent with the functional class indicated in ***Table 1***. In addition, the functions of the corresponding proteins were examined, which demonstrated that all SNPs could cause residue change except for HSPD1 rs8539, summarized in ***Table 3***. In addition, MT-ND5 rs10517616 was not estimated here because no data was available publicly.

###### 

mRNA expression by the genotypes of SNPs with the data from HapMap

  Category     No.   Mean±SEM        *P*^a^      *P*^b^
  ------------ ----- --------------- ----------- --------
  rs3775728    　    　              　          　
  TT           55    10.56±0.04378               NA
  CT           3     10.84±0.11230   0.1536      
  rs7671281                                      
  TT           52    6.067±0.01329               NA
  CT           4     6.046±0.03729   0.6837      
  rs3796704                                      
  GG           53    6.065±0.01309               NA
  AG           3     6.062±0.04807   0.9500      
  rs8539                                         
  CC           31    6.198±0.01135               0.9718
  CT           19    6.190±0.01628   0.6832      
  TT           5     6.194±0.02530   0.8887      
  CT+TT        24    6.191±0.01370   0.6868      
  rs2076472                                      
  TT           37    6.311±0.01794               NA
  CT           19    6.291±0.01970   0.4927      
  rs9808377                                      
  AA           37    6.426±0.01331               0.7668
  AG           16    6.409±0.01801   0.4692      
  GG           3     6.398±0.05742   0.5726      
  AG+GG        19    6.408±0.01692   0.3997      
  rs1001238                                      
  TT           35    6.427±0.01354               0.7663
  CT           18    6.410±0.01765   0.4561      
  CC           3     6.398±0.05742   0.5616      
  CT+CC        21    6.408±0.01658   0.3918      
  rs2042995                                      
  TT           37    6.426±0.01331               0.7668
  CT           16    6.409±0.01801   0.4692      
  CC           3     6.398±0.05742   0.5726      
  CT+CC        19    6.408±0.01692   0.3997      
  rs3829746                                      
  TT           36    6.429±0.01335               0.5472
  CT           17    6.404±0.01768   0.2779      
  CC           3     6.398±0.05742   0.5305      
  CT+CC        20    6.403±0.01661   0.2376      
  rs2042996                                      
  GG           36    6.426±0.01368               0.787
  AG           17    6.410±0.01695   0.4921      
  AA           3     6.398±0.05742   0.5787      
  AG+AA        20    6.409±0.01608   0.4213      
  rs2243682                                      
  GG           38    8.850±0.06324               0.5172
  AG           16    8.949±0.11200   0.4196      
  AA           1     9.41940207      NA          
  AG+AA        17    8.976±0.10870   0.2934      
  rs2615542                                      
  AA           38    8.850±0.06324               0.522
  AG           17    8.945±0.10520   0.4215      
  GG           1     9.41940207      NA          
  AG+GG        18    8.972±0.10260   0.2979      
  rs13213957                                     
  TT           72    6.067±0.01000               0.1051
  CT           16    6.033±0.01920   0.1453      
  CC           1     5.926081        NA          
  TT+CT        17    6.027±0.01910   0.0785^c^   　

SNP: single nucleotide polymorphism; NA: not available. ^a^ Two-side Student\'s t test within the stratum. ^b^*P* values for one way ANOVA of mRNA expression among different genotypes for each SNP. ^c^ Marginal *P* value (in bold).

###### 

Residue changes by the genotypes of SNPs with the data from dbSNP

  SNP         Gene        Protein position   Residue change
  ----------- ----------- ------------------ ----------------
  rs3775728   *GRSF1*     194                Val-to-Ile
  rs7671281   *ENAM*      648                Ile-to-Thr
  rs3796704   *ENAM*      763                Arg-to-Gln
  rs8539      *HSPD1*     91                 Lys-to-Lys
  rs2076472   *APOBEC2*   136                Ile-to-Thr
  rs9808377   *TTN*       20346              Ile-to-Thr
  rs1001238   *TTN*       9651               Asn-to-Asp
  rs2042995   *TTN*       10221              Ile-to-Val
  rs3829746   *TTN*       18725              Ile-to-Val
  rs2042996   *TTN*       12353              Thr-to-Ile
  rs2243682   *CENPE*     1942               Thr-to-Met
  rs2615542   *CENPE*     1535               Phe-to-Leu

SNP: single nucleotide polymorphism.

During the ICSNPathway analysis, six pathways about usual weekday bedtime were detected and are summarized in ***Table 4***. The first mechanism involved MT-ND5 rs10517616 polymorphism (nonsynonymous coding) in pathways such as NADH dehydrogenase activity (nominal *P*\<0.001, FDR=0.011), respiratory electron transport chain (nominal *P*=0.001, FDR=0.011), oxidoreductase activity (nominal *P*=0.002, FDR=0.017), and oxidative phosphorylation (nominal *P*=0.004, FDR=0.047). The second was GRSF1 rs3775728 polymorphism (nonsynonymous coding) in mRNA binding pathway (nominal *P*\<0.001, FDR=0.014). The third one included ENAM rs7671281, rs3796704 polymorphisms (nonsynonymous coding) in pathway of biomineral formation (nominal *P*\<0.001, FDR=0.021).

###### 

Candidate pathways for circadian phenotypes

  Index                          Candidate pathway                      Description                                                                                                                                                                                                                                                                                                                                                                                                                *P*~N~    FDR
  ------------------------------ -------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------- -------
  Usual weekday bedtime                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
  1                              NADH dehydrogenase activity            GO:0003954. Catalysis of the reaction: NADH+ H+ + acceptor=NAD+ + reduced acceptor.                                                                                                                                                                                                                                                                                                                                        \<0.001   0.011
  2                              Respiratory electron transport chain   GO:0022904. A process whereby a series of electron carriers operate together to transfer electrons from donors such as NADH and FADH2 to any of several different terminal electron acceptors to generate a transmembrane electrochemical gradient.                                                                                                                                                                        0.001     0.011
  3                              mRNA binding                           GO:0003729. Interacting selectively with pre-messenger RNA (pre-mRNA) or messenger RNA (mRNA).                                                                                                                                                                                                                                                                                                                             \<0.001   0.014
  4                              Oxidoreductase activity                GO:0016655. Catalysis of an oxidation-reduction (redox) reaction in which NADH or NADPH acts as a hydrogen or electron donor and reduces a quinone or a similar acceptor molecule.                                                                                                                                                                                                                                         0.002     0.017
  5                              Biomineral formation                   GO:0031214. Formation of hard tissues that consist mainly of inorganic compounds, and also contain a small amounts of organic matrices that are believed to play important roles in their formation.                                                                                                                                                                                                                       \<0.001   0.021
  6                              Oxidative phosphorylation              GO:0006119. The phosphorylation of ADP to ATP that accompanies the oxidation of a metabolite through the operation of the respiratory chain. Oxidation of compounds establishes a proton gradient across the membrane, providing the energy for ATP synthesis.                                                                                                                                                             0.004     0.047
  Usual weekday sleep duration                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  1                              Unfolded protein binding               GO:0051082. Interacting selectively with an unfolded protein.                                                                                                                                                                                                                                                                                                                                                              0.001     0.03
  2                              mRNA processing                        GO:0006397. Any process involved in the conversion of a primary mRNA transcript into one or more mature mRNA(s) prior to translation into polypeptide.                                                                                                                                                                                                                                                                     \<0.001   0.031
  3                              Cell cycle                             GO:0007049. The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division.   \<0.001   0.036
  4                              RNA processing                         GO:0006396. Any process involved in the conversion of one or more primary RNA transcripts into one or more mature RNA molecules.                                                                                                                                                                                                                                                                                           0.002     0.039
  5                              Anion transport                        GO:0006820. The directed movement of anions, atoms or small molecules with a net negative charge, into, out of, within or between cells.                                                                                                                                                                                                                                                                                   \<0.001   0.042
  6                              mRNA binding                           GO:0003729. Interacting selectively with pre-messenger RNA (pre-mRNA) or messenger RNA (mRNA).                                                                                                                                                                                                                                                                                                                             \<0.001   0.042

*P*~N~: nominal *P* value; FDR: false discovery rate; GO: gene ontology.

In the ICSNPathway analysis of usual weekday sleep duration, six pathways were found and are presented in ***Table 4*** similarly. The first was HSPD1 rs8539 polymorphism (nonsynonymous coding) in the unfolded protein binding pathway (nominal *P*=0.001 FDR=0.03). The second one was APOBEC2 rs2076472 polymorphism (nonsynonymous coding) in pathway of mRNA processing (nominal *P*\<0.001, FDR=0.031). The third mechanism involved GRSF1 rs3775728 polymorphism (nonsynonymous coding) in pathways containing mRNA processing (nominal *P*\<0.001, FDR=0.031), RNA processing (nominal *P*=0.002, FDR=0.039), and mRNA binding (nominal *P*\<0.001, FDR=0.042). The fourth pathway consisted of TTN rs9808377, rs1001238, rs2042995, rs3829746, rs2042996, and CENPE rs2243682, rs2615542 polymorphisms (nonsynonymous coding) in cell cycle (nominal *P*\<0.001, FDR=0.036). The last one was SLC17A1 rs13213957 polymorphism (regulatory region) in the anion transport pathway (nominal *P*\<0.001, FDR=0.042).

Discussion
==========

A compound molecular network may make a significant contribution to the development of circadian phenotypes, containing several cellular pathways^\[[@R31]\]^. GWASs are limited to detect single SNP associations and identify new loci, so we applied a pathway-based pattern to take the biological interplay between multiple genes into consideration, and propose novel views into how genes might help the development of circadian phenotypes^\[[@R32]\]^.

In this study, we applied ICSNPathway analysis to identify six potential regulating mechanisms, respectively, in usual weekday bedtime and sleep duration. The most significant SNP-to-gene-to-effect hypothesis was that rs10517616 changes the feature of MT-ND5 in NADH dehydrogenase activity^\[[@R33]\]^. It was reported that NADH promoted the transcription of the lactate dehydrogenase (*LDH*) gene under redox state. This is based on the activation of *E*-box by binding heterodimer Bmal1/NPAS2, the master brain clock to regulate circadian rhythmicity^\[[@cit34a]\]^. The second candidate gene GRSF1 found in this study and previous studies has been implied in the pathway of mRNA binding through SNP rs3775728^\[[@R34]--[@R35]\]^. The third biological mechanism involves the modulation of ENAM by rs7671281 and rs3796704 to affect its role in mineral formation^\[[@R36]--[@R37]\]^. The forth one involves the influence of rs8539 on HSPD1 in unfolded protein binding^\[[@R38]\]^. The fifth involves the modulation of APOBEC2 by rs2076472 to affect mRNA processing. The sixth involves the modulation of TTN by rs9808377, rs1001238, rs2042995, rs3829746, and rs2042996 as well as CENPE by rs2243682 and rs2615542 to influence its role in cell cycle^\[[@R39]\]^. The seventh involves the modulation of SLC17A1 by rs13213957 to affect anion transport^\[[@R40]--[@R41]\]^, which could influence the mRNA expression of SLC17A1.

As far as we know, these mechanisms of circadian phenotypes, including MT-ND5, GRSF1, ENAM, HSPD1, APOBEC2, TTN, CENPE and SLC17A1, have been firstly identified in our study. The ICSNPathway analysis has been conducted to identify candidate causal genes relevant to disease-related phenotypes such as rheumatoid arthritis^\[[@R20]\]^. Thus, the results received in our study might help the development of novel hypotheses for the further investigations.

Even though the abovementioned biological mechanisms may affect circadian phenotypes, several limitations should be acknowledged. Firstly, the data was obtained from only 749 subjects^\[[@R16]\]^, which may limit the application to the whole populations and weaken the authority to identify the candidate SNPs. Secondly, with no study supplying strong supports for these results, the candidate SNP-gene-pathways should be verified in more studies.

In short, our results demonstrated fifteen candidate SNPs in eight genes (MT-ND5 rs10517616, GRSF1 rs3775728, ENAM rs7671281, rs3796704, HSPD1 rs8539, APOBEC2 rs2076472, GRSF1 rs3775728, TTN rs9808377, rs1001238, rs2042995, rs3829746, rs2042996, CENPE rs2243682, rs2615542 and SLC17A1 rs13213957 polymorphisms), which participate in six hypothetical pathways involved in usual weekday bedtime and six potential pathways implicated usual weekday sleep duration. However, further investigations are warranted to validate the identified genetic variations in the biological pathways related to circadian phenotypes.
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